Skip to main content
. 2019 Dec 31;21(1):281. doi: 10.3390/ijms21010281

Figure 3.

Figure 3

Diagram of DDX3X alternations by compounds. The changes in DDX3X activity and expression level along with downstream signaling upon (A) Ginsenoside Rg3, (B) RK-33, (C) Rottlerin, (D) NZ51, or (E) doxorubicin addition in various types of cancer are represented.